Drug

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response. Read More

Bringing a new drug to market is an increasingly daunting – and expensive – task. Today it costs more than $1 billion and takes more than seven years, on average, to complete the human studies required for a drug to be approved for marketing. Only about one in five drugs… Read More